105 related articles for article (PubMed ID: 22090211)
1. Characterization of intracellular localization of PrP(Sc) in prion-infected cells using a mAb that recognizes the region consisting of aa 119-127 of mouse PrP.
Yamasaki T; Suzuki A; Shimizu T; Watarai M; Hasebe R; Horiuchi M
J Gen Virol; 2012 Mar; 93(Pt 3):668-680. PubMed ID: 22090211
[TBL] [Abstract][Full Text] [Related]
2. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells.
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
PLoS One; 2014; 9(9):e106516. PubMed ID: 25181483
[TBL] [Abstract][Full Text] [Related]
4. Retrograde Transport by Clathrin-Coated Vesicles is Involved in Intracellular Transport of PrP
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
Sci Rep; 2018 Aug; 8(1):12241. PubMed ID: 30115966
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.
Shan Z; Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
Prion; 2016 Jul; 10(4):305-18. PubMed ID: 27565564
[TBL] [Abstract][Full Text] [Related]
6. Flow Cytometric Detection of PrP
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
[TBL] [Abstract][Full Text] [Related]
7. Comparison of abnormal isoform of prion protein in prion-infected cell lines and primary-cultured neurons by PrPSc-specific immunostaining.
Tanaka M; Fujiwara A; Suzuki A; Yamasaki T; Hasebe R; Masujin K; Horiuchi M
J Gen Virol; 2016 Aug; 97(8):2030-2042. PubMed ID: 27267758
[TBL] [Abstract][Full Text] [Related]
8. Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.
Yamasaki T; Baron GS; Suzuki A; Hasebe R; Horiuchi M
Virology; 2014 Feb; 450-451():324-35. PubMed ID: 24503096
[TBL] [Abstract][Full Text] [Related]
9. Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane.
Goold R; McKinnon C; Rabbanian S; Collinge J; Schiavo G; Tabrizi SJ
J Cell Sci; 2013 Aug; 126(Pt 16):3552-62. PubMed ID: 23813960
[TBL] [Abstract][Full Text] [Related]
10. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein.
Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207
[TBL] [Abstract][Full Text] [Related]
12. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
13. Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation.
Kiachopoulos S; Heske J; Tatzelt J; Winklhofer KF
Traffic; 2004 Jun; 5(6):426-36. PubMed ID: 15117317
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells.
Dron M; Dandoy-Dron F; Farooq Salamat MK; Laude H
J Gen Virol; 2009 Aug; 90(Pt 8):2050-2060. PubMed ID: 19339478
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation.
Gilch S; Bach C; Lutzny G; Vorberg I; Schätzl HM
Cell Mol Life Sci; 2009 Dec; 66(24):3979-91. PubMed ID: 19823766
[TBL] [Abstract][Full Text] [Related]
17. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
Sakudo A; Wu G; Onodera T; Ikuta K
Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
[TBL] [Abstract][Full Text] [Related]
18. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
Pimpinelli F; Lehmann S; Maridonneau-Parini I
Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
[TBL] [Abstract][Full Text] [Related]
19. PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein.
Tayebi M; Taylor WA; Jones DR; Bate C; David M
J Gen Virol; 2010 Aug; 91(Pt 8):2121-2131. PubMed ID: 20375226
[TBL] [Abstract][Full Text] [Related]
20. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.
Enari M; Flechsig E; Weissmann C
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9295-9. PubMed ID: 11470893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
